Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell depleting therapy with rituximab

Blood

Volumn 112, Issue 4, 2008, Pages 1147-1150

  Stasi, Roberto ^a   Cooper, Nichola ^b   Poeta, Giovanni Del ^c   Stipa, Elisa ^d   Evangelista, Maria Laura ^a   Abruzzese, Elisabetta ^d   Amadori, Sergio ^c  

^a REGINA APOSTOLORUM HOSPITAL   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^d S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TREATMENT RESPONSE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; METHODOLOGY; MIDDLE AGED;

ADULT; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTES, REGULATORY;

EID: 51649091745     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-12-129262     Document Type: Article

References (16)

1. Stasi R, Evangelista ML Stipa E, Buccisano F Venditti A, Amadori S. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost. 2008;99:4-13.
2. Coopamah MD; Garvey MB, Freedman J, Semple JW. Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update. Transtus Med Rev. 2003;17:69-80.
3. Stasi R, Del Poeta G, Stipa E, et al. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood. 2007;110:2924-2930.
4. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
5. Lohr J. Knoechel B. Abbas AK. Regulatory T cells in the periphery. Immunol Rev. 2006;212:149-162.
6. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity. 2006;25: 195-201.
7. Rouse BT. Regulatory T cells in health and disease. J Intern Med. 2007;262:78-95.
8. Valencia X, Lipsky PE. CD4+CD25+FoxP3+regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007;3:619-626.
9. Liu B, Zhao H, Poon MC, et al. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol. 2007;78:139-143.
10. Sakakura M, Wada H, Tawara l, et al. Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res. 2007; 120:187-193.
11. Ling Y. CaoX. Yu Z, Ruan C. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol. 2007;79:310-316.
12. Filion MC, Proulx C, Bradley AJ; et al. Presence in peripheral blood of healthy individuals of auto-reactive T cells to a membrane antigen present on bone marrow-derived cells. Blood. 1996;88: 2144-2150.
13. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-llla in immune thrombocytopenic purpura. Role in production of antiplatelet autoantibody. J Clin Invest. 1998;102: 1393-1402.
14. Semple JW, Milev Y Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood. 1996;87:4245-4254.
15. Fogarty PR Rick ME. Zeng W, Risitano AM, Dunbar GE; Bussel JB. Tcell receptor VB repertoire diversity in patients with immune thrombocy-topenia following splenectomy. Clin Exp Immunol. 2003;133:461-466.
16. Olsson B, Andersson PO; Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123-1124.